These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11777497)

  • 21. Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Allen MH; Feifel D; Lesem MD; Zimbroff DL; Ross R; Munzar P; Spyker DA; Cassella JV
    J Clin Psychiatry; 2011 Oct; 72(10):1313-21. PubMed ID: 21294997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation.
    Castle DJ; Udristoiu T; Kim CY; Sarosi A; Pidrman V; Omar AN; Rosales JI; Melamed Y; Isik T; Karagianis J; Treuer T
    World J Biol Psychiatry; 2009; 10(1):43-53. PubMed ID: 19137460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A naturalistic comparison study of the efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular levomepromazine in acute agitated patients with schizophrenia.
    Suzuki H; Gen K; Takahashi Y
    Hum Psychopharmacol; 2014 Jan; 29(1):83-8. PubMed ID: 24424709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. German version, inter- and intrarater reliability and internal consistency of the "Agitated Behavior Scale" (ABS-G) in patients with moderate to severe traumatic brain injury.
    Hellweg S; Schuster-Amft C
    Health Qual Life Outcomes; 2016 Jul; 14(1):106. PubMed ID: 27431448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transition from ziprasidone im to oral formulation in agitated patients with acute exacerbation of schizophrenia: an open trial.
    Mautone A; Scarone S;
    Pharmacopsychiatry; 2011 Jul; 44(5):173-8. PubMed ID: 21751127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP; Spina E; Murray S; Yang R
    Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of agitation in the acute psychiatric setting. An observational study of the effectiveness of intramuscular psychotropic medication.
    Bauer JØ; Stenborg D; Lodahl T; Mønsted MM
    Nord J Psychiatry; 2016 Nov; 70(8):599-605. PubMed ID: 27284637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reliability and validity of the Norwegian version of the Brief Agitation Rating Scale (BARS) in dementia.
    Sommer OH; Engedal K
    Aging Ment Health; 2011 Mar; 15(2):252-8. PubMed ID: 21140306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The InterSePT scale for suicidal thinking reliability and validity.
    Lindenmayer JP; Czobor P; Alphs L; Nathan AM; Anand R; Islam Z; Chou JC;
    Schizophr Res; 2003 Sep; 63(1-2):161-70. PubMed ID: 12892870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validity and Reliability Study of Turkish Version of Clinical Assessment Interview for Negative Symptoms (CAINS).
    Vayisoğlu S; Karahan S; Gürel ŞC; Yağcioğlu AEA
    Noro Psikiyatr Ars; 2024; 61(1):59-65. PubMed ID: 38496217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan.
    Hsu WY; Huang SS; Lee BS; Chiu NY
    J Clin Psychopharmacol; 2010 Jun; 30(3):230-4. PubMed ID: 20473056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics].
    Bartkó G; Trixler M; Bitter I; Degrell I; Füredi J; Faludi G;
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):201-9. PubMed ID: 17211055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
    Buckley PF; Paulsson B; Brecher M
    J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychometric testing of the Agitation Severity Scale for acute presentation behavioral management patients in the emergency department.
    Strout TD
    Adv Emerg Nurs J; 2014; 36(3):250-70. PubMed ID: 25076401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the use of the positive and negative syndrome scale-excited component as a criterion for administration of p.r.n. medication.
    Chaichan W
    J Psychiatr Pract; 2008 Mar; 14(2):105-13. PubMed ID: 18360196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Olanzapine orally-disintegrating tablet in severe psychotic agitation: a naturalistic study.
    Pascual JC; Pérez V; Martín JL; Safont G; Puigdemont D; Alvarez E
    Actas Esp Psiquiatr; 2007; 35(1):47-51. PubMed ID: 17323225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: prospective studies are needed.
    Barzman DH; DelBello MP; Forrester JJ; Keck PE; Strakowski SM
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):503-9. PubMed ID: 17822344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Global Impression of Improvement (CGI-I) as a valid proxy measure for remission in schizophrenia: analyses of ziprasidone clinical study data.
    Masand P; O'Gorman C; Mandel FS
    Schizophr Res; 2011 Mar; 126(1-3):174-83. PubMed ID: 21185155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inter-rater reliability of ratings on the six-item Positive and Negative Syndrome Scale (PANSS-6) obtained using the Simplified Negative and Positive Symptoms Interview (SNAPSI).
    Kølbæk P; Blicher AB; Buus CW; Feller SG; Holm T; Dines D; O'Leary KM; Sørensen RS; Opler M; Correll CU; Mors O; Bech P; Østergaard SD
    Nord J Psychiatry; 2018 Aug; 72(6):431-436. PubMed ID: 30037286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reliability and validity of the Japanese version of the Agitated Behaviour in Dementia Scale in Alzheimer's disease: three dimensions of agitated behaviour in dementia.
    Torii K; Nakaaki S; Banno K; Murata Y; Sato J; Tatsumi H; Yamanaka K; Narumoto J; Mimura M; Akechi T; Furukawa TA
    Psychogeriatrics; 2011 Dec; 11(4):212-20. PubMed ID: 22151240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.